| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ATF7 TCF7 ETV7 SREBF1 NR4A2 POU3F4 BCOR ZKSCAN5 TFAP2A HESX1 E2F8 TFE3 HOXA2 NFE2L3 ZNF526 PER2 NFATC3 MTF1 ZNF341 SPZ1 KLF5 TET1 ZNF70 FOXI2 ZFHX3 PAX5 EP300 ZNF574 | 4.07e-07 | 1459 | 135 | 28 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ATF7 TCF7 SREBF1 NR4A2 POU3F4 ZKSCAN5 TFAP2A HESX1 E2F8 TFE3 HOXA2 NFE2L3 ZNF526 PER2 NFATC3 MTF1 ZNF341 SPZ1 KLF5 TET1 FOXI2 ZFHX3 PAX5 EP300 ZNF574 | 8.28e-07 | 1244 | 135 | 25 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ATF7 TCF7 SREBF1 NR4A2 POU3F4 ZKSCAN5 TFAP2A HESX1 E2F8 TFE3 HOXA2 NFE2L3 ZNF526 PER2 NFATC3 MTF1 ZNF341 SPZ1 KLF5 TET1 FOXI2 ZFHX3 PAX5 EP300 ZNF574 | 1.22e-06 | 1271 | 135 | 25 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF438 ATF7 TCF7 ETV7 SREBF1 NR4A2 POU3F4 ZKSCAN5 TFAP2A HESX1 E2F8 TFE3 HOXA2 NFE2L3 ZNF526 KMT2D NFATC3 MTF1 ZNF341 SPZ1 KLF5 ZNF70 FOXI2 ZFHX3 PAX5 ZNF574 | 2.47e-06 | 1412 | 135 | 26 | GO:0000981 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MTA2 TCF20 DAB2 GON4L NLRP1 BCOR TFAP2A ARID5A PPP2R3A ARID1B KMT2D PER2 CIITA ABI2 BRD4 MDC1 GAB4 TRIM8 TJP2 N4BP2L2 CAPRIN1 MAML3 EP300 | 3.06e-06 | 1160 | 135 | 23 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | MTA2 TCF20 GON4L BCOR TFAP2A ARID5A ARID1B KMT2D PER2 CIITA BRD4 TRIM8 N4BP2L2 MAML3 EP300 | 6.28e-06 | 562 | 135 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | MTA2 TCF20 TFAP2A ARID1B KMT2D PER2 CIITA BRD4 TRIM8 MAML3 EP300 | 6.92e-06 | 303 | 135 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.65e-05 | 8 | 135 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 3.50e-05 | 10 | 135 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | MTA2 TCF20 DAB2 GON4L NLRP1 BCOR TFAP2A ARID5A PPP2R3A ARID1B KMT2D PER2 CIITA ABI2 BRD4 MDC1 GAB4 TRIM8 TJP2 N4BP2L2 CAPRIN1 MAML3 EP300 | 3.79e-05 | 1356 | 135 | 23 | GO:0060090 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 6.53e-05 | 320 | 135 | 10 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 7.62e-05 | 326 | 135 | 10 | GO:0001217 | |
| GeneOntologyMolecularFunction | 5-methylcytosine dioxygenase activity | 1.36e-04 | 3 | 135 | 2 | GO:0070579 | |
| GeneOntologyMolecularFunction | chromatin binding | MTA2 SREBF1 MLLT10 TFAP2A BAHD1 ARID5A HESX1 PHC2 BAP1 PHC3 ARID1B NFATC3 BRD4 MCM9 EP300 | 1.45e-04 | 739 | 135 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | histone modifying activity | 1.68e-04 | 229 | 135 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 3.17e-04 | 20 | 135 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone deubiquitinase activity | 1.24e-03 | 8 | 135 | 2 | GO:0140934 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.52e-03 | 73 | 135 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SREBF1 NR4A2 TFAP2A TFE3 KMT2D NFATC3 MTF1 ZNF341 KLF5 PAX5 ZNF574 | 1.62e-03 | 566 | 135 | 11 | GO:0001216 |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 1.69e-03 | 35 | 135 | 3 | GO:0051019 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 2.40e-03 | 11 | 135 | 2 | GO:0099122 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF438 MTA2 ATF7 TCF7 ETV7 SREBF1 NR4A2 DAB2 GON4L BCOR TFAP2A BAHD1 ARID5A HESX1 E2F8 PHC2 BAP1 HOXA2 NFE2L3 PHC3 PER2 CIITA NFATC3 KLF5 TET1 N4BP2L2 ZFHX3 PAX5 MAGEC1 EP300 | 4.80e-09 | 1399 | 134 | 30 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZNF438 MTA2 ATF7 TCF7 ETV7 SREBF1 NR4A2 DAB2 GON4L BCOR TFAP2A BAHD1 ARID5A HESX1 E2F8 PHC2 BAP1 HOXA2 NFE2L3 PHC3 PER2 CIITA NFATC3 KLF5 TET1 N4BP2L2 ZFHX3 PAX5 MAGEC1 EP300 | 6.04e-09 | 1413 | 134 | 30 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MTA2 TET2 ATF7 TCF20 SREBF1 NR4A2 DAB2 TSC2 MLLT10 TFAP2A ARID5A E2F8 TFE3 HOXA2 KMT2D CIITA NFATC3 MTF1 SPZ1 KLF5 BRD4 MDC1 TET1 ZFHX3 PAX5 MAML3 EP300 ZNF574 | 6.56e-08 | 1390 | 134 | 28 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | MTA2 ATF7 TCF7 ETV7 SREBF1 NR4A2 DAB2 BCOR TFAP2A ARID5A HESX1 E2F8 HOXA2 NFE2L3 PER2 CIITA NFATC3 KLF5 TET1 N4BP2L2 ZFHX3 PAX5 MAGEC1 EP300 | 7.05e-08 | 1053 | 134 | 24 | GO:0000122 |
| GeneOntologyBiologicalProcess | embryo development | ATF7 TCF7 CLASP1 CECR2 DAB2 LAMA3 TRIOBP POU3F4 TSC2 TNRC6C BCOR PLXNB2 TFAP2A HESX1 E2F8 BAP1 HOXA2 PPP2R3A KMT2D BRD4 TET1 SEC24B N4BP2L2 PAX5 STRC USPL1 EP300 STRCP1 | 1.31e-07 | 1437 | 134 | 28 | GO:0009790 |
| GeneOntologyBiologicalProcess | neuron development | RPGRIP1 KREMEN1 CECR2 SAMD4B RAB11A NR4A2 DAB2 LAMA3 TRIOBP TSC2 PLXNB2 TFAP2A OPHN1 HOXA2 ARID1B ATXN2 ABI2 ARHGAP44 MYPN TET1 SEC24B TMEM108 STRC GOLGA8A CAPRIN1 EP300 STRCP1 | 6.71e-07 | 1463 | 134 | 27 | GO:0048666 |
| GeneOntologyBiologicalProcess | chordate embryonic development | ATF7 TCF7 CECR2 DAB2 TSC2 BCOR PLXNB2 TFAP2A E2F8 BAP1 HOXA2 PPP2R3A KMT2D BRD4 TET1 SEC24B N4BP2L2 PAX5 USPL1 EP300 | 1.63e-06 | 906 | 134 | 20 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ATF7 TCF7 CECR2 DAB2 TSC2 BCOR PLXNB2 TFAP2A E2F8 BAP1 HOXA2 PPP2R3A KMT2D BRD4 TET1 SEC24B N4BP2L2 PAX5 USPL1 EP300 | 2.39e-06 | 929 | 134 | 20 | GO:0009792 |
| GeneOntologyBiologicalProcess | neuron projection development | KREMEN1 CECR2 RAB11A NR4A2 DAB2 LAMA3 TRIOBP TSC2 PLXNB2 OPHN1 HOXA2 ARID1B ATXN2 ABI2 ARHGAP44 MYPN TET1 SEC24B TMEM108 STRC GOLGA8A CAPRIN1 EP300 STRCP1 | 2.54e-06 | 1285 | 134 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | NR4A2 LAMA3 TRIOBP TSC2 PLXNB2 OPHN1 HOXA2 ABI2 ARHGAP44 MYPN TET1 SEC24B STRC GOLGA8A CAPRIN1 EP300 STRCP1 | 7.26e-06 | 748 | 134 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | ear morphogenesis | 7.57e-06 | 154 | 134 | 8 | GO:0042471 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | RPGRIP1 TRIOBP POU3F4 TFAP2A HESX1 HOXA2 PPP2R3A ABI2 SEC24B STRC STRCP1 | 1.53e-05 | 343 | 134 | 11 | GO:0090596 |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 2.16e-05 | 129 | 134 | 7 | GO:0042472 | |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 2.28e-05 | 26 | 134 | 4 | GO:0060088 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 2.40e-05 | 53 | 134 | 5 | GO:0060122 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | USP36 MTA2 TET2 SETD1B KMT2B CECR2 BCOR BAHD1 BAP1 ARID1B KMT2D PER2 BAZ1A BRD4 TET1 EP300 | 2.57e-05 | 741 | 134 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | cell morphogenesis | NR4A2 DAB2 LAMA3 TRIOBP TSC2 PLXNB2 OPHN1 BAP1 HOXA2 ATXN2 ABI2 ARHGAP44 MYPN TET1 SEC24B TMEM108 STRC GOLGA8A CAPRIN1 EP300 STRCP1 | 2.87e-05 | 1194 | 134 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | auditory receptor cell morphogenesis | 4.68e-05 | 31 | 134 | 4 | GO:0002093 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | TCF7 CLASP1 CECR2 TRIOBP POU3F4 TSC2 TNRC6C PLXNB2 TFAP2A HESX1 HOXA2 SEC24B PAX5 STRC STRCP1 | 6.28e-05 | 713 | 134 | 15 | GO:0048598 |
| GeneOntologyBiologicalProcess | epithelium development | TCF7 CLASP1 CECR2 DAB2 TRIOBP TSC2 PLXNB2 TFAP2A HESX1 E2F8 OPHN1 PPP2R3A CSF1 NFATC3 ABI2 KLF5 SEC24B TJP2 STRC ADAMTSL4 HYDIN EP300 STRCP1 | 7.01e-05 | 1469 | 134 | 23 | GO:0060429 |
| GeneOntologyBiologicalProcess | chromatin organization | USP36 MTA2 TET2 SETD1B KMT2B CECR2 BCOR BAHD1 BAP1 ARID1B KMT2D PER2 BAZ1A BRD4 MDC1 TET1 EP300 | 7.16e-05 | 896 | 134 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | TCF7 TRIOBP POU3F4 TFAP2A HESX1 HOXA2 SEC24B PAX5 STRC STRCP1 | 1.01e-04 | 351 | 134 | 10 | GO:0048562 |
| GeneOntologyBiologicalProcess | ear development | 1.05e-04 | 285 | 134 | 9 | GO:0043583 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 1.13e-04 | 73 | 134 | 5 | GO:0060119 | |
| GeneOntologyBiologicalProcess | macrophage homeostasis | 1.25e-04 | 3 | 134 | 2 | GO:0061519 | |
| GeneOntologyBiologicalProcess | auditory receptor cell development | 1.30e-04 | 40 | 134 | 4 | GO:0060117 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | NR4A2 LAMA3 TSC2 PLXNB2 OPHN1 HOXA2 ATXN2 ABI2 ARHGAP44 MYPN TET1 TMEM108 GOLGA8A CAPRIN1 EP300 | 2.28e-04 | 802 | 134 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | inner ear development | 2.53e-04 | 253 | 134 | 8 | GO:0048839 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | USP36 MTA2 TET2 SETD1B KMT2B CECR2 BCOR BAHD1 BAP1 ARID1B KMT2D PER2 BAZ1A BRD4 MDC1 TET1 EP300 | 2.63e-04 | 999 | 134 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | NR4A2 LAMA3 TSC2 PLXNB2 OPHN1 HOXA2 ATXN2 ABI2 ARHGAP44 MYPN TET1 TMEM108 GOLGA8A CAPRIN1 EP300 | 2.86e-04 | 819 | 134 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | embryonic organ development | TCF7 TRIOBP POU3F4 TNRC6C TFAP2A HESX1 E2F8 HOXA2 SEC24B PAX5 STRC STRCP1 | 3.02e-04 | 561 | 134 | 12 | GO:0048568 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 3.12e-04 | 330 | 134 | 9 | GO:0040029 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | NR4A2 LAMA3 TSC2 PLXNB2 OPHN1 HOXA2 ATXN2 ABI2 ARHGAP44 MYPN TET1 TMEM108 GOLGA8A CAPRIN1 EP300 | 3.13e-04 | 826 | 134 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive T cell selection | 3.90e-04 | 53 | 134 | 4 | GO:0043368 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | SPN DAB2 TRIOBP PTPN23 TSC2 TFE3 ARID1B CSF1 BRD4 NID1 ZFHX3 EP300 | 4.02e-04 | 579 | 134 | 12 | GO:0045785 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 4.09e-04 | 96 | 134 | 5 | GO:0060113 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 4.32e-04 | 23 | 134 | 3 | GO:2000318 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TET2 RPGRIP1 TCF7 ETV7 LAMA3 TRIOBP POU3F4 BCOR TFAP2A HESX1 HOXA2 PPP2R3A CSF1 ABI2 SEC24B PAX5 STRC EP300 STRCP1 | 5.57e-04 | 1269 | 134 | 19 | GO:0009887 |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 5.90e-04 | 104 | 134 | 5 | GO:0042490 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | TET2 TCF7 SPN GON4L TFE3 BAP1 ARID1B CSF1 NFATC3 BRD4 GAB4 TJP2 PAX5 EP300 | 6.27e-04 | 789 | 134 | 14 | GO:0002521 |
| GeneOntologyBiologicalProcess | T-helper cell lineage commitment | 7.00e-04 | 27 | 134 | 3 | GO:0002295 | |
| GeneOntologyCellularComponent | transcription regulator complex | MTA2 ATF7 TCF7 NR4A2 TFAP2A ARID5A E2F8 TFE3 NFE2L3 PER2 NFATC3 KLF5 N4BP2L2 ZFHX3 PAX5 EP300 | 1.73e-06 | 596 | 136 | 16 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | MTA2 ATF7 TCF7 CECR2 ETV7 SREBF1 NR4A2 GON4L POU3F4 TFAP2A HESX1 E2F8 TFE3 PHC2 HOXA2 NFE2L3 ARID1B NFATC3 BAZ1A KLF5 BRD4 TET1 FOXI2 ZFHX3 PAX5 EP300 | 2.93e-06 | 1480 | 136 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MTA2 ATF7 RANBP2 TCF7 SETD1B KMT2B CECR2 GON4L BCOR SAGE2P BAHD1 E2F8 PHC2 BAP1 NFE2L3 PHC3 ARID1B ZC3H11A KMT2D PER2 BAZ1A BRD4 TET1 AFF1 | 8.58e-06 | 1377 | 136 | 24 | GO:0140513 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 4.12e-04 | 96 | 136 | 5 | GO:0070603 | |
| Domain | EPHD | 1.53e-05 | 22 | 131 | 4 | PS51805 | |
| Domain | Bromodomain_CS | 3.07e-05 | 26 | 131 | 4 | IPR018359 | |
| Domain | Tet_JBP | 4.88e-05 | 2 | 131 | 2 | PF12851 | |
| Domain | 2OGFeDO_noxygenase_dom | 4.88e-05 | 2 | 131 | 2 | IPR024779 | |
| Domain | Tet_JBP | 4.88e-05 | 2 | 131 | 2 | SM01333 | |
| Domain | Znf_FYVE_PHD | 8.02e-05 | 147 | 131 | 7 | IPR011011 | |
| Domain | BROMODOMAIN_1 | 1.28e-04 | 37 | 131 | 4 | PS00633 | |
| Domain | Bromodomain | 1.42e-04 | 38 | 131 | 4 | PF00439 | |
| Domain | Post-SET_dom | 1.77e-04 | 16 | 131 | 3 | IPR003616 | |
| Domain | PostSET | 1.77e-04 | 16 | 131 | 3 | SM00508 | |
| Domain | POST_SET | 1.77e-04 | 16 | 131 | 3 | PS50868 | |
| Domain | BROMODOMAIN_2 | 1.91e-04 | 41 | 131 | 4 | PS50014 | |
| Domain | Bromodomain | 2.10e-04 | 42 | 131 | 4 | IPR001487 | |
| Domain | BROMO | 2.10e-04 | 42 | 131 | 4 | SM00297 | |
| Domain | - | 2.10e-04 | 42 | 131 | 4 | 1.20.920.10 | |
| Domain | Rho_GTPase_activation_prot | 3.87e-04 | 88 | 131 | 5 | IPR008936 | |
| Domain | PHD | 4.07e-04 | 89 | 131 | 5 | SM00249 | |
| Domain | Znf_PHD | 4.51e-04 | 91 | 131 | 5 | IPR001965 | |
| Domain | FYrich_C | 4.82e-04 | 5 | 131 | 2 | IPR003889 | |
| Domain | FYrich_N | 4.82e-04 | 5 | 131 | 2 | IPR003888 | |
| Domain | FYRC | 4.82e-04 | 5 | 131 | 2 | SM00542 | |
| Domain | FYRN | 4.82e-04 | 5 | 131 | 2 | SM00541 | |
| Domain | Znf_FCS | 4.82e-04 | 5 | 131 | 2 | IPR012313 | |
| Domain | FYRN | 4.82e-04 | 5 | 131 | 2 | PF05964 | |
| Domain | FYRC | 4.82e-04 | 5 | 131 | 2 | PF05965 | |
| Domain | FYRC | 4.82e-04 | 5 | 131 | 2 | PS51543 | |
| Domain | FYRN | 4.82e-04 | 5 | 131 | 2 | PS51542 | |
| Domain | ZF_PHD_2 | 5.50e-04 | 95 | 131 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 5.77e-04 | 96 | 131 | 5 | PS01359 | |
| Domain | ZF_FCS | 7.19e-04 | 6 | 131 | 2 | PS51024 | |
| Domain | RhoGAP | 9.41e-04 | 62 | 131 | 4 | SM00324 | |
| Domain | RhoGAP | 1.00e-03 | 63 | 131 | 4 | PF00620 | |
| Domain | RhoGAP_dom | 1.06e-03 | 64 | 131 | 4 | IPR000198 | |
| Domain | RHOGAP | 1.06e-03 | 64 | 131 | 4 | PS50238 | |
| Domain | - | 1.06e-03 | 64 | 131 | 4 | 1.10.555.10 | |
| Domain | PHD | 1.91e-03 | 75 | 131 | 4 | PF00628 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | MTA2 TCF7 SETD1B KMT2B NR4A2 TSC2 ZKSCAN5 TFAP2A E2F8 PHC2 PHC3 KMT2D ZFHX3 PAX5 ZNF839 MAML3 EP300 | 2.26e-05 | 768 | 99 | 17 | MM14851 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | MTA2 RANBP2 TCF7 SETD1B KMT2B NR4A2 TSC2 ZKSCAN5 TFAP2A E2F8 PHC2 PHC3 ZC3H11A KMT2D ZFHX3 RPRD2 PAX5 ZNF839 MAML3 EP300 | 2.33e-05 | 1022 | 99 | 20 | MM15436 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MTA2 TCF7 SETD1B KMT2B SREBF1 NR4A2 TSC2 TNRC6C ZKSCAN5 TFAP2A E2F8 PHC2 PHC3 ARID1B ZC3H11A KMT2D MDC1 ZNF70 ZFHX3 RPRD2 PAX5 ZNF839 MAML3 EP300 | 2.36e-05 | 1387 | 99 | 24 | M734 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 4.29e-05 | 237 | 99 | 9 | M27786 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 9.99e-05 | 153 | 99 | 7 | MM15522 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.27e-04 | 37 | 99 | 4 | M27797 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.50e-04 | 44 | 99 | 4 | MM15527 | |
| Pathway | REACTOME_SUMOYLATION | 3.67e-04 | 189 | 99 | 7 | M27214 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 4.03e-04 | 137 | 99 | 6 | M48232 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 4.15e-04 | 254 | 99 | 8 | M27131 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 4.88e-04 | 142 | 99 | 6 | MM15576 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 5.43e-04 | 95 | 99 | 5 | M48268 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 5.69e-04 | 96 | 99 | 5 | M27792 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 CRYBG2 SETD1B KMT2B RHBDF2 SREBF1 TSC2 TNRC6C MLLT10 PLXNB2 BAHD1 TFE3 PHC2 BAP1 ITPR2 ZC3H11A KMT2D PER2 ZNF341 BRD4 ARHGAP44 DUSP16 NINL LRRC56 HMGXB3 ZNF839 EP300 SOWAHB | 4.14e-15 | 1105 | 138 | 28 | 35748872 |
| Pubmed | MTA2 TCF7 TCF20 SREBF1 NR4A2 POU3F4 MLLT10 ZKSCAN5 TFAP2A HESX1 TFE3 PER2 MTF1 BAZ1A KLF5 BRD4 TRIM8 ZFHX3 HMGXB3 PAX5 MAML3 | 8.57e-13 | 709 | 138 | 21 | 22988430 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | MTA2 TCF7 TCF20 ETV7 SREBF1 POU3F4 MLLT10 ZKSCAN5 TFAP2A HESX1 E2F8 HOXA2 PER2 CIITA NFATC3 MTF1 SPZ1 ZNF70 HMGXB3 MAML3 EP300 | 4.56e-11 | 877 | 138 | 21 | 20211142 |
| Pubmed | TET2 TCF7 KMT2B TCF20 ETV7 GON4L PROSER1 TNRC6C MLLT10 BCOR TFE3 BAP1 PHC3 ARID1B KMT2D ATXN2 NFATC3 SPZ1 KLF5 MDC1 SEC24B ZFHX3 RPRD2 PCDH7 CAPRIN1 EP300 | 7.50e-11 | 1429 | 138 | 26 | 35140242 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ATF7 TCF7 ETV7 SREBF1 NR4A2 GON4L POU3F4 TFAP2A HESX1 E2F8 TFE3 HOXA2 NFE2L3 ZC3H11A KMT2D NFATC3 MTF1 KLF5 FOXI2 ZFHX3 PAX5 | 8.62e-11 | 908 | 138 | 21 | 19274049 |
| Pubmed | MTA2 KMT2B TCF20 PTPN23 BCOR TFAP2A ARID1B ZC3H11A KMT2D BRD4 MDC1 TET1 SEC24B TJP2 RPRD2 EP300 | 6.82e-10 | 549 | 138 | 16 | 38280479 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 RANBP2 KMT2B TCF20 PROSER1 BCOR ARID1B KMT2D BAZ1A MDC1 TET1 ZFHX3 EP300 | 1.72e-09 | 351 | 138 | 13 | 38297188 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANBP2 KMT2B TCF20 CLASP1 SAMD4B DAB2 BCOR PHC2 BAP1 PHC3 ZC3H11A KMT2D FAM13A BRD4 MDC1 TJP2 AFF1 PCDH7 | 1.97e-09 | 774 | 138 | 18 | 15302935 |
| Pubmed | TET2 RANBP2 KMT2B TCF20 RBBP8NL BCOR BAP1 PHC3 KMT2D KIF15 BRD4 TET1 ZFHX3 | 1.38e-08 | 418 | 138 | 13 | 34709266 | |
| Pubmed | USP36 TET2 TBRG4 CECR2 TRIOBP BCOR BAHD1 BAP1 ARID1B MDC1 TET1 NINL RPRD2 HMGXB3 | 2.82e-08 | 529 | 138 | 14 | 14621295 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ATF7 TCF7 ETV7 SREBF1 NR4A2 POU3F4 TFAP2A HESX1 E2F8 TFE3 HOXA2 NFATC3 MTF1 KLF5 | 3.98e-08 | 544 | 138 | 14 | 28473536 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | USP36 MTA2 ATF7 RANBP2 KMT2B TCF20 SREBF1 BCOR TFAP2A TFE3 PHC2 BAP1 PHC3 ZC3H11A KMT2D BAZ1A KLF5 BRD4 MDC1 RPRD2 EP300 | 4.42e-08 | 1294 | 138 | 21 | 30804502 |
| Pubmed | Epigenomic analysis of gastrulation identifies a unique chromatin state for primed pluripotency. | 6.11e-08 | 3 | 138 | 3 | 31844322 | |
| Pubmed | Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity. | 6.11e-08 | 3 | 138 | 3 | 29662175 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 TCF20 CLASP1 COBLL1 SAMD4B TSC2 E2F8 FAM13A NFATC3 STARD9 BRD4 TET1 SEC24B TJP2 MPHOSPH9 SH3RF3 PCDH7 | 6.18e-08 | 861 | 138 | 17 | 36931259 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 TCF20 CECR2 GON4L NLRP1 BCOR HOXA2 PHC3 ARID1B KMT2D BRD4 EP300 | 7.13e-08 | 398 | 138 | 12 | 35016035 |
| Pubmed | 1.30e-07 | 268 | 138 | 10 | 33640491 | ||
| Pubmed | ZNF438 MTA2 ATF7 TCF7 TCF20 SREBF1 MLLT10 TFAP2A HESX1 TFE3 MTF1 BAZ1A KLF5 BRD4 ZFHX3 HMGXB3 | 1.49e-07 | 808 | 138 | 16 | 20412781 | |
| Pubmed | USP36 RANBP2 TRIOBP PTPN23 BCOR SGO1 TFAP2A ITPR2 PPP2R3A ARID1B KMT2D KIF15 ATXN2 ABI2 DUSP16 SEC24B MPHOSPH9 PCDH7 | 1.98e-07 | 1049 | 138 | 18 | 27880917 | |
| Pubmed | 2.33e-07 | 157 | 138 | 8 | 30186101 | ||
| Pubmed | MTA2 TET2 ATF7 RANBP2 KMT2B TCF20 CLASP1 BCOR TFAP2A E2F8 ARID1B ZC3H11A KMT2D ATXN2 KLF5 BRD4 CAPRIN1 EP300 | 4.11e-07 | 1103 | 138 | 18 | 34189442 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 34667079 | ||
| Pubmed | 1.03e-06 | 83 | 138 | 6 | 28794006 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.15e-06 | 134 | 138 | 7 | 25452129 | |
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 8896557 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 27694924 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATF7 RHBDF2 SAMD4B LAMA3 TRIOBP TNRC6C RBBP8NL CCDC57 PPP2R3A ZC3H11A FAM13A ATXN2 ARHGAP44 AFF1 ZFHX3 RPRD2 ZNF839 SH3RF3 MAML3 EP300 | 1.85e-06 | 1489 | 138 | 20 | 28611215 |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 2.11e-06 | 283 | 138 | 9 | 18854154 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | TRIOBP TSC2 PHC2 KIAA1549L FAM13A ABI2 ARHGAP44 NINL RPRD2 USPL1 ADAMTSL4 CAPRIN1 | 2.62e-06 | 560 | 138 | 12 | 21653829 |
| Pubmed | 2.66e-06 | 152 | 138 | 7 | 38360978 | ||
| Pubmed | 3.37e-06 | 8 | 138 | 3 | 22266653 | ||
| Pubmed | Transcriptional programs that control expression of the autoimmune regulator gene Aire. | 3.37e-06 | 8 | 138 | 3 | 27941786 | |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 3.37e-06 | 8 | 138 | 3 | 23130995 | |
| Pubmed | 3.45e-06 | 102 | 138 | 6 | 10231032 | ||
| Pubmed | RANBP2 TCF20 COBLL1 DAB2 LAMA3 PTPN23 KIAA1549L DUSP16 MPHOSPH9 ZNF839 EP300 | 4.14e-06 | 486 | 138 | 11 | 20936779 | |
| Pubmed | 4.44e-06 | 396 | 138 | 10 | 26687479 | ||
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 22665483 | ||
| Pubmed | RANBP2 TBRG4 COBLL1 SAMD4B DAB2 ZC3H11A FAM13A MYPN TJP2 RPRD2 ZNF574 | 5.74e-06 | 503 | 138 | 11 | 16964243 | |
| Pubmed | FKBP15 RANBP2 TCF20 CLASP1 PRR36 TRIOBP TSC2 BCOR KIF15 ATXN2 NFATC3 ABI2 ARHGAP44 GOLGA8A CAPRIN1 | 7.11e-06 | 963 | 138 | 15 | 28671696 | |
| Pubmed | USP36 RANBP2 KMT2B CLASP1 SAMD4B RAB11A TRIOBP GON4L BCOR PHC2 PHC3 ZC3H11A ATXN2 ABI2 BAZ1A MDC1 SEC24B ZFHX3 ZNF574 | 7.70e-06 | 1497 | 138 | 19 | 31527615 | |
| Pubmed | TCF7 TBRG4 TCF20 RAB11A BCOR TFAP2A TFE3 ARID1B KMT2D TRIM8 MAML3 EP300 | 9.77e-06 | 638 | 138 | 12 | 31182584 | |
| Pubmed | 1.00e-05 | 34 | 138 | 4 | 26288816 | ||
| Pubmed | 1.09e-05 | 263 | 138 | 8 | 20932939 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.15e-05 | 349 | 138 | 9 | 25665578 | |
| Pubmed | 1.26e-05 | 75 | 138 | 5 | 25593309 | ||
| Pubmed | 1.31e-05 | 12 | 138 | 3 | 27563068 | ||
| Pubmed | 1.53e-05 | 78 | 138 | 5 | 28611094 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21357426 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27362828 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24606892 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24606891 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30045709 | ||
| Pubmed | Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells. | 1.56e-05 | 2 | 138 | 2 | 23415914 | |
| Pubmed | Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. | 1.56e-05 | 2 | 138 | 2 | 12640139 | |
| Pubmed | Ten-Eleven Translocation Proteins Modulate the Response to Environmental Stress in Mice. | 1.56e-05 | 2 | 138 | 2 | 30540950 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 32114381 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35955629 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35640156 | ||
| Pubmed | Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells. | 1.56e-05 | 2 | 138 | 2 | 24474761 | |
| Pubmed | Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination. | 1.56e-05 | 2 | 138 | 2 | 30606231 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34165552 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34910522 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26328763 | ||
| Pubmed | P300 binds to and acetylates MTA2 to promote colorectal cancer cells growth. | 1.56e-05 | 2 | 138 | 2 | 24468085 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34632336 | ||
| Pubmed | BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. | 1.56e-05 | 2 | 138 | 2 | 19578371 | |
| Pubmed | Structural insight into substrate preference for TET-mediated oxidation. | 1.56e-05 | 2 | 138 | 2 | 26524525 | |
| Pubmed | CD169-CD43 interaction is involved in erythroblastic island formation and erythroid differentiation. | 1.56e-05 | 2 | 138 | 2 | 36861412 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22456611 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12384788 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 11687802 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24214992 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18774944 | ||
| Pubmed | Ten-eleven translocation protein 1 modulates medulloblastoma progression. | 1.56e-05 | 2 | 138 | 2 | 33926529 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24672749 | ||
| Pubmed | A primary role of TET proteins in establishment and maintenance of De Novo bivalency at CpG islands. | 1.56e-05 | 2 | 138 | 2 | 27288448 | |
| Pubmed | Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation. | 1.56e-05 | 2 | 138 | 2 | 26598602 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 14615581 | ||
| Pubmed | Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders. | 1.56e-05 | 2 | 138 | 2 | 35506254 | |
| Pubmed | Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice. | 1.56e-05 | 2 | 138 | 2 | 26586431 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35075236 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27778125 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35342356 | ||
| Pubmed | Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome. | 1.56e-05 | 2 | 138 | 2 | 30228234 | |
| Pubmed | Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion. | 1.56e-05 | 2 | 138 | 2 | 28877054 | |
| Pubmed | TET-dependent regulation of retrotransposable elements in mouse embryonic stem cells. | 1.56e-05 | 2 | 138 | 2 | 27863519 | |
| Pubmed | Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. | 1.56e-05 | 2 | 138 | 2 | 28783731 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28252217 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31311407 | ||
| Pubmed | DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy. | 1.60e-05 | 364 | 138 | 9 | 31391242 | |
| Pubmed | 1.70e-05 | 13 | 138 | 3 | 26989192 | ||
| Pubmed | USP36 MTA2 TCF20 CLASP1 DAB2 PTPN23 ARID1B BAZ1A RPRD2 CAPRIN1 | 2.03e-05 | 472 | 138 | 10 | 38943005 | |
| Pubmed | 2.15e-05 | 14 | 138 | 3 | 20854876 | ||
| Pubmed | KMT2B SYTL2 DAB2 ARID1B KMT2D ZNF341 BAZ1A BRD4 AFF1 NID1 PAPPA | 2.56e-05 | 591 | 138 | 11 | 15231748 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.69e-05 | 146 | 138 | 6 | 23892456 | |
| Pubmed | PTPN23 BCOR E2F8 HAVCR1 PHC3 ARID1B ZC3H11A ZNF341 BAZ1A MYPN TET1 TJP2 AFF1 N4BP2L2 HMGXB3 | 2.83e-05 | 1084 | 138 | 15 | 11544199 | |
| Pubmed | 3.30e-05 | 16 | 138 | 3 | 23870121 | ||
| Pubmed | 3.30e-05 | 16 | 138 | 3 | 24368734 | ||
| Pubmed | KMT2B SREBF1 DAB2 BCOR ARID5A PHC2 HAVCR1 PPP2R3A KIAA1549L ATXN2 DMPK | 3.31e-05 | 608 | 138 | 11 | 16713569 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.31e-05 | 608 | 138 | 11 | 36089195 | |
| Interaction | TOP3B interactions | MTA2 CRYBG2 SETD1B KMT2B RHBDF2 SAMD4B SREBF1 TSC2 TNRC6C MLLT10 PLXNB2 BAHD1 TFE3 PHC2 BAP1 ITPR2 ZC3H11A KMT2D PER2 ATXN2 ZNF341 BRD4 ARHGAP44 MDC1 DUSP16 SEC24B NINL LRRC56 HMGXB3 ZNF839 ADAMTSL4 CAPRIN1 EP300 SOWAHB | 1.06e-10 | 1470 | 135 | 34 | int:TOP3B |
| Interaction | KLF5 interactions | MTA2 TET2 SREBF1 MLLT10 BCOR TFE3 BAP1 ARID1B KMT2D KLF5 BRD4 EP300 | 7.85e-09 | 195 | 135 | 12 | int:KLF5 |
| Interaction | SMG7 interactions | TCF20 SAMD4B TNRC6C MLLT10 BCOR ARID1B KMT2D ATXN2 DUSP16 TET1 NINL TJP2 RPRD2 CAPRIN1 | 3.18e-08 | 319 | 135 | 14 | int:SMG7 |
| Interaction | TBR1 interactions | 6.88e-08 | 113 | 135 | 9 | int:TBR1 | |
| Interaction | TLE3 interactions | TET2 TCF20 CECR2 PROSER1 MLLT10 BCOR BAP1 PHC3 ARID1B KMT2D KLF5 BRD4 ZFHX3 EP300 | 2.41e-07 | 376 | 135 | 14 | int:TLE3 |
| Interaction | PIN1 interactions | KMT2B GPR152 DAB2 TSC2 RBBP8NL ARID5A SSC5D ZNF526 ABI2 BRD4 DMPK ADAMTSL4 CAPRIN1 EP300 | 3.01e-07 | 383 | 135 | 14 | int:PIN1 |
| Interaction | CLTC interactions | USP36 TET2 FKBP15 RANBP2 RAB11A DAB2 PTPN23 NLRP1 TFAP2A TFE3 BAP1 PER2 MTF1 BRD4 SEC24B NINL PCDH7 EP300 | 3.96e-07 | 655 | 135 | 18 | int:CLTC |
| Interaction | FEV interactions | 1.14e-06 | 203 | 135 | 10 | int:FEV | |
| Interaction | DPY30 interactions | 1.19e-06 | 204 | 135 | 10 | int:DPY30 | |
| Interaction | HDAC1 interactions | USP36 MTA2 TET2 RANBP2 KMT2B TCF20 SREBF1 GON4L BCOR BAHD1 TFE3 BAP1 KMT2D KIF15 CIITA BAZ1A KLF5 BRD4 TET1 AFF1 ZFHX3 CAPRIN1 EP300 | 1.21e-06 | 1108 | 135 | 23 | int:HDAC1 |
| Interaction | SOX7 interactions | 1.30e-06 | 82 | 135 | 7 | int:SOX7 | |
| Interaction | YWHAH interactions | TET2 TCF20 RHBDF2 CLASP1 COBLL1 SAMD4B TSC2 E2F8 TFE3 BAP1 FAM13A NFATC3 ABI2 STARD9 BRD4 DUSP16 TET1 SEC24B NINL TJP2 MPHOSPH9 SH3RF3 | 4.00e-06 | 1102 | 135 | 22 | int:YWHAH |
| Interaction | DCTN2 interactions | MTA2 CLASP1 RAB11A SGO1 BAP1 KIF15 ABI2 NINL MPHOSPH9 CAPRIN1 EP300 ZNF574 | 5.06e-06 | 356 | 135 | 12 | int:DCTN2 |
| Interaction | WWTR1 interactions | MTA2 TCF20 PTPN23 BCOR TFAP2A ARID5A ARID1B KMT2D KLF5 BRD4 SEC24B RPRD2 EP300 | 5.36e-06 | 422 | 135 | 13 | int:WWTR1 |
| Interaction | HNF1B interactions | 5.48e-06 | 190 | 135 | 9 | int:HNF1B | |
| Interaction | YWHAZ interactions | TET2 CLASP1 COBLL1 SAMD4B TSC2 BCOR E2F8 TFE3 BAP1 FAM13A PER2 KIF15 NFATC3 ABI2 STARD9 BRD4 MDC1 DUSP16 TJP2 ZFYVE19 MPHOSPH9 ZNF839 PCDH7 EP300 | 6.73e-06 | 1319 | 135 | 24 | int:YWHAZ |
| Interaction | DCAF7 interactions | TSC2 BCOR ARID5A BAP1 ATXN2 BAZ1A BRD4 SEC24B NINL EP300 SOWAHB ZNF574 | 7.09e-06 | 368 | 135 | 12 | int:DCAF7 |
| Interaction | PAX8 interactions | 9.85e-06 | 111 | 135 | 7 | int:PAX8 | |
| Interaction | KDM6A interactions | 1.37e-05 | 162 | 135 | 8 | int:KDM6A | |
| Interaction | ZNF526 interactions | 1.62e-05 | 80 | 135 | 6 | int:ZNF526 | |
| Interaction | KDM1A interactions | MTA2 TET2 RANBP2 KMT2B TCF20 RBBP8NL BCOR BAHD1 HESX1 PHC2 BAP1 PHC3 KMT2D KIF15 SPZ1 BRD4 TET1 ZFHX3 EP300 | 1.68e-05 | 941 | 135 | 19 | int:KDM1A |
| Interaction | H2BC21 interactions | MTA2 KMT2B TCF20 MLLT10 BCOR TFAP2A ARID5A PHC2 ARID1B KIAA1549L BAZ1A BRD4 MDC1 TET1 RPRD2 EP300 | 1.74e-05 | 696 | 135 | 16 | int:H2BC21 |
| Interaction | NUCKS1 interactions | 1.78e-05 | 220 | 135 | 9 | int:NUCKS1 | |
| Interaction | H2BC3 interactions | USP36 MTA2 RANBP2 TCF20 GON4L BAP1 HOXA2 KMT2D BAZ1A BRD4 MDC1 EP300 | 1.89e-05 | 406 | 135 | 12 | int:H2BC3 |
| Interaction | NUP43 interactions | USP36 MTA2 RANBP2 SETD1B KMT2B TCF20 GON4L BCOR SGO1 PHC3 ARID1B KMT2D BAZ1A MDC1 ZFHX3 | 1.98e-05 | 625 | 135 | 15 | int:NUP43 |
| Interaction | ERG interactions | 1.98e-05 | 223 | 135 | 9 | int:ERG | |
| Interaction | EGR2 interactions | 2.02e-05 | 171 | 135 | 8 | int:EGR2 | |
| Interaction | NANOG interactions | MTA2 RANBP2 KMT2B TCF20 CECR2 SAMD4B BCOR TFE3 PPP2R3A ARID1B KLF5 TET1 EP300 | 2.15e-05 | 481 | 135 | 13 | int:NANOG |
| Interaction | IRF4 interactions | 2.29e-05 | 85 | 135 | 6 | int:IRF4 | |
| Interaction | PHC1 interactions | 2.45e-05 | 86 | 135 | 6 | int:PHC1 | |
| Interaction | PAX9 interactions | 2.76e-05 | 130 | 135 | 7 | int:PAX9 | |
| Interaction | YWHAG interactions | TET2 CLASP1 COBLL1 SAMD4B RAB11A TSC2 E2F8 TFE3 BAP1 FAM13A KIF15 NFATC3 BAZ1A STARD9 DUSP16 TET1 SEC24B NINL TJP2 MPHOSPH9 SH3RF3 PCDH7 | 2.80e-05 | 1248 | 135 | 22 | int:YWHAG |
| Interaction | SCMH1 interactions | 3.04e-05 | 54 | 135 | 5 | int:SCMH1 | |
| Interaction | YWHAE interactions | MTA2 TET2 CLASP1 COBLL1 SAMD4B TSC2 E2F8 TFE3 BAP1 HAVCR1 FAM13A PER2 ABI2 BRD4 DUSP16 TET1 TJP2 MPHOSPH9 ZNF839 SH3RF3 PCDH7 CAPRIN1 | 3.08e-05 | 1256 | 135 | 22 | int:YWHAE |
| Interaction | ALG13 interactions | 3.29e-05 | 183 | 135 | 8 | int:ALG13 | |
| Interaction | FOXI1 interactions | 3.59e-05 | 92 | 135 | 6 | int:FOXI1 | |
| Interaction | MTA2 interactions | USP36 MTA2 TCF20 BCOR TFE3 BAP1 BAZ1A KLF5 BRD4 MYPN CAPRIN1 EP300 | 3.71e-05 | 435 | 135 | 12 | int:MTA2 |
| Interaction | SP7 interactions | TET2 KMT2B TCF20 PROSER1 BCOR ARID1B KMT2D RPRD2 PCDH7 EP300 | 3.94e-05 | 304 | 135 | 10 | int:SP7 |
| Interaction | SMAP2 interactions | 4.14e-05 | 189 | 135 | 8 | int:SMAP2 | |
| Interaction | ASF1A interactions | 4.70e-05 | 249 | 135 | 9 | int:ASF1A | |
| Interaction | SIN3A interactions | MTA2 TET2 TCF20 SREBF1 NR4A2 GON4L PER2 BRD4 MDC1 TET1 EP300 | 5.14e-05 | 380 | 135 | 11 | int:SIN3A |
| Interaction | NAP1L4 interactions | 7.60e-05 | 206 | 135 | 8 | int:NAP1L4 | |
| Interaction | DTX2 interactions | TCF20 DAB2 BCOR CCDC57 TFAP2A ARID5A MDC1 RPRD2 PAX5 ABHD16A | 7.81e-05 | 330 | 135 | 10 | int:DTX2 |
| Interaction | CENPH interactions | 7.97e-05 | 106 | 135 | 6 | int:CENPH | |
| Interaction | NONO interactions | TET2 DAB2 PROSER1 E2F8 TFE3 BAP1 ZC3H11A PER2 MTF1 BRD4 NINL PCDH7 EP300 | 8.34e-05 | 549 | 135 | 13 | int:NONO |
| Interaction | GCM1 interactions | 9.30e-05 | 68 | 135 | 5 | int:GCM1 | |
| Interaction | SOX5 interactions | 1.11e-04 | 162 | 135 | 7 | int:SOX5 | |
| Interaction | TNRC6B interactions | RPGRIP1 SAMD4B PTPN23 TNRC6C ATXN2 SEC24B NINL MPHOSPH9 CAPRIN1 | 1.22e-04 | 282 | 135 | 9 | int:TNRC6B |
| Interaction | SEC16A interactions | SAMD4B RAB11A PTPN23 TNRC6C BCOR BAP1 ATXN2 KLF5 DUSP16 SEC24B LAMP3 | 1.42e-04 | 426 | 135 | 11 | int:SEC16A |
| Interaction | POU5F1 interactions | MTA2 TCF20 TSC2 MLLT10 TFAP2A TFE3 PPP2R3A ARID1B KLF5 BRD4 MDC1 TET1 ZFHX3 | 1.54e-04 | 584 | 135 | 13 | int:POU5F1 |
| Interaction | TLX3 interactions | 1.54e-04 | 291 | 135 | 9 | int:TLX3 | |
| Interaction | UBN1 interactions | 1.68e-04 | 77 | 135 | 5 | int:UBN1 | |
| Interaction | MBD3 interactions | 1.71e-04 | 295 | 135 | 9 | int:MBD3 | |
| Interaction | USP7 interactions | USP36 TET2 TCF20 COBLL1 SREBF1 GON4L BCOR OPHN1 PHC2 BAP1 ZC3H11A KMT2D CSF1 KIAA1549L IPCEF1 BRD4 MDC1 MYPN TRIM8 NINL EP300 | 1.72e-04 | 1313 | 135 | 21 | int:USP7 |
| Interaction | TLX1 interactions | 1.80e-04 | 175 | 135 | 7 | int:TLX1 | |
| Interaction | TSC1 interactions | CLASP1 RAB11A SREBF1 DAB2 TRIOBP TSC2 ARID5A SEC24B LAMP3 NINL | 1.82e-04 | 366 | 135 | 10 | int:TSC1 |
| Interaction | XRCC5 interactions | USP36 SGO1 TFAP2A TFE3 BAP1 MTF1 BAZ1A BRD4 MDC1 NINL PCDH7 EP300 | 1.83e-04 | 515 | 135 | 12 | int:XRCC5 |
| Interaction | SOX2 interactions | MTA2 TET2 RANBP2 TCF20 SAMD4B RAB11A LAMA3 TRIOBP PROSER1 BCOR TFAP2A TFE3 PHC2 ITPR2 PHC3 ARID1B KMT2D KLF5 ZFHX3 MAGEC1 CAPRIN1 EP300 | 1.90e-04 | 1422 | 135 | 22 | int:SOX2 |
| Interaction | CREBBP interactions | SREBF1 ARID5A BAP1 ARID1B KMT2D CIITA MTF1 KLF5 BRD4 MDC1 PAPPA PAX5 EP300 | 1.97e-04 | 599 | 135 | 13 | int:CREBBP |
| Interaction | TFAP2C interactions | 2.12e-04 | 44 | 135 | 4 | int:TFAP2C | |
| Interaction | SMAD3 interactions | MTA2 KMT2B DAB2 TSC2 TFE3 PHC2 ARID1B KLF5 PAPPA ZFHX3 EP300 | 2.15e-04 | 447 | 135 | 11 | int:SMAD3 |
| Interaction | HDAC2 interactions | USP36 MTA2 TET2 TCF20 BAHD1 TFE3 PHC2 BAP1 CIITA BAZ1A KLF5 BRD4 TET1 RPRD2 CAPRIN1 EP300 | 2.24e-04 | 865 | 135 | 16 | int:HDAC2 |
| Interaction | CPAP interactions | 2.29e-04 | 182 | 135 | 7 | int:CPAP | |
| Interaction | KHSRP interactions | 2.35e-04 | 308 | 135 | 9 | int:KHSRP | |
| Interaction | CEBPA interactions | MTA2 TET2 RPGRIP1 ATF7 RANBP2 KMT2B TCF20 CLASP1 BCOR TFAP2A E2F8 ARID1B ZC3H11A KMT2D ATXN2 BAZ1A KLF5 BRD4 CAPRIN1 EP300 | 2.36e-04 | 1245 | 135 | 20 | int:CEBPA |
| Interaction | EYA4 interactions | 2.37e-04 | 243 | 135 | 8 | int:EYA4 | |
| Interaction | YY1 interactions | MTA2 ATF7 KMT2B SREBF1 GON4L TFAP2A BAP1 PHC3 BRD4 MDC1 EP300 | 2.45e-04 | 454 | 135 | 11 | int:YY1 |
| Interaction | MYB interactions | 2.76e-04 | 133 | 135 | 6 | int:MYB | |
| Interaction | SH3KBP1 interactions | 2.77e-04 | 315 | 135 | 9 | int:SH3KBP1 | |
| Interaction | BICD1 interactions | 2.87e-04 | 250 | 135 | 8 | int:BICD1 | |
| Interaction | SIRT6 interactions | MTA2 RANBP2 SETD1B BCOR ITPR2 ARID1B BRD4 MDC1 N4BP2L2 RPRD2 PCDH7 CAPRIN1 EP300 | 3.11e-04 | 628 | 135 | 13 | int:SIRT6 |
| Interaction | CRX interactions | 3.19e-04 | 254 | 135 | 8 | int:CRX | |
| Interaction | BACH2 interactions | 3.49e-04 | 90 | 135 | 5 | int:BACH2 | |
| Interaction | CITED4 interactions | 3.58e-04 | 21 | 135 | 3 | int:CITED4 | |
| Interaction | MLLT10 interactions | 3.77e-04 | 51 | 135 | 4 | int:MLLT10 | |
| Interaction | SUDS3 interactions | 3.78e-04 | 141 | 135 | 6 | int:SUDS3 | |
| Interaction | HCFC2 interactions | 3.86e-04 | 92 | 135 | 5 | int:HCFC2 | |
| Interaction | GATA2 interactions | 3.93e-04 | 199 | 135 | 7 | int:GATA2 | |
| Interaction | RCC1 interactions | 4.17e-04 | 201 | 135 | 7 | int:RCC1 | |
| Interaction | CTNNB1 interactions | USP36 MTA2 RANBP2 TCF7 SPN RAB11A MLLT10 TFAP2A BAP1 ZC3H11A KMT2D KLF5 BRD4 SEC24B TJP2 CAPRIN1 EP300 | 4.20e-04 | 1009 | 135 | 17 | int:CTNNB1 |
| Interaction | YWHAB interactions | TET2 CLASP1 COBLL1 SAMD4B TSC2 E2F8 TFE3 BAP1 FAM13A NFATC3 ABI2 STARD9 DUSP16 NINL TJP2 MPHOSPH9 SH3RF3 | 4.44e-04 | 1014 | 135 | 17 | int:YWHAB |
| Interaction | TUBB2B interactions | 4.70e-04 | 205 | 135 | 7 | int:TUBB2B | |
| Interaction | RBPJL interactions | 4.72e-04 | 23 | 135 | 3 | int:RBPJL | |
| Interaction | YWHAQ interactions | TET2 CLASP1 COBLL1 SAMD4B TSC2 E2F8 TFE3 BAP1 FAM13A NFATC3 BAZ1A STARD9 BRD4 DUSP16 TET1 TJP2 MPHOSPH9 PCDH7 | 4.84e-04 | 1118 | 135 | 18 | int:YWHAQ |
| Interaction | BMI1 interactions | RANBP2 TSC2 BCOR PHC2 ITPR2 PHC3 ZC3H11A ATXN2 BAZ1A BRD4 SEC24B CAPRIN1 EP300 | 4.92e-04 | 659 | 135 | 13 | int:BMI1 |
| Interaction | SOX9 interactions | 4.93e-04 | 97 | 135 | 5 | int:SOX9 | |
| Interaction | NASP interactions | 4.98e-04 | 207 | 135 | 7 | int:NASP | |
| Interaction | CIITA interactions | 5.04e-04 | 55 | 135 | 4 | int:CIITA | |
| Interaction | PCGF1 interactions | 5.12e-04 | 208 | 135 | 7 | int:PCGF1 | |
| Interaction | PHF21A interactions | 5.15e-04 | 343 | 135 | 9 | int:PHF21A | |
| Interaction | NFIC interactions | 5.42e-04 | 210 | 135 | 7 | int:NFIC | |
| Interaction | SMARCA2 interactions | 5.49e-04 | 346 | 135 | 9 | int:SMARCA2 | |
| Interaction | FHL3 interactions | 5.53e-04 | 276 | 135 | 8 | int:FHL3 | |
| Interaction | NUP35 interactions | RANBP2 TCF20 GMIP BCOR TFAP2A ARID1B KMT2D ATXN2 MAML3 EP300 | 5.82e-04 | 424 | 135 | 10 | int:NUP35 |
| Interaction | H3C14 interactions | 6.46e-04 | 156 | 135 | 6 | int:H3C14 | |
| Interaction | FXR1 interactions | ZNF438 RANBP2 CECR2 TRIOBP BCOR PHC2 BAP1 KIAA1549L ATXN2 BRD4 ADAMTSL4 CAPRIN1 EP300 | 6.50e-04 | 679 | 135 | 13 | int:FXR1 |
| Interaction | SIGLEC1 interactions | 6.56e-04 | 6 | 135 | 2 | int:SIGLEC1 | |
| Interaction | SCML1 interactions | 6.59e-04 | 59 | 135 | 4 | int:SCML1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 8.65e-05 | 147 | 138 | 5 | chr15q15 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 9.79e-06 | 25 | 99 | 4 | 775 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.61e-04 | 50 | 99 | 4 | 721 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.81e-04 | 181 | 99 | 6 | 694 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.42e-04 | 34 | 99 | 3 | 487 | |
| GeneFamily | PHD finger proteins | 1.51e-03 | 90 | 99 | 4 | 88 | |
| GeneFamily | Zinc fingers CXXC-type | 1.89e-03 | 12 | 99 | 2 | 136 | |
| GeneFamily | AT-rich interaction domain containing | 2.98e-03 | 15 | 99 | 2 | 418 | |
| GeneFamily | Actins|Deafness associated genes | 3.45e-03 | 113 | 99 | 4 | 1152 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN | 2.10e-07 | 26 | 136 | 5 | M7999 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN | 2.10e-07 | 26 | 136 | 5 | MM510 | |
| Coexpression | BENPORATH_NOS_TARGETS | 4.53e-06 | 179 | 136 | 8 | M14573 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP | 8.49e-06 | 195 | 136 | 8 | M4405 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 9.14e-06 | 197 | 136 | 8 | M9916 | |
| Coexpression | GSE17721_LPS_VS_CPG_12H_BMDC_UP | 9.84e-06 | 199 | 136 | 8 | M4005 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | CD248 SREBF1 NR4A2 DAB2 BCOR HAVCR1 FAM13A PER2 ABI2 STARD9 PAPPA | 1.04e-05 | 411 | 136 | 11 | M1351 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | CD248 SREBF1 NR4A2 DAB2 BCOR HAVCR1 FAM13A PER2 ABI2 STARD9 PAPPA | 1.16e-05 | 416 | 136 | 11 | MM1002 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | TET2 RANBP2 KREMEN1 RHBDF2 ARID5A PHC2 CSF1 DUSP16 SEC24B TJP2 AFF1 | 1.22e-05 | 418 | 136 | 11 | M12676 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | TET2 RANBP2 KREMEN1 RHBDF2 ARID5A PHC2 CSF1 DUSP16 SEC24B TJP2 AFF1 | 1.76e-05 | 435 | 136 | 11 | MM1221 |
| Coexpression | BENPORATH_OCT4_TARGETS | 2.16e-05 | 290 | 136 | 9 | M17183 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | USP36 KMT2B TCF20 GON4L ZKSCAN5 BAHD1 FAM13A PER2 MTF1 KLF5 BRD4 SEC24B N4BP2L2 USPL1 EP300 | 2.51e-05 | 822 | 136 | 15 | M6782 |
| Coexpression | CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 | 2.80e-05 | 68 | 136 | 5 | M305 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_ACTIVATED_T_CELLS | 5.64e-05 | 128 | 136 | 6 | M43603 | |
| Coexpression | GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP | 7.60e-05 | 196 | 136 | 7 | M3668 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 8.36e-05 | 199 | 136 | 7 | M7607 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP | 8.36e-05 | 199 | 136 | 7 | M7845 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 8.63e-05 | 200 | 136 | 7 | M7839 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 9.65e-05 | 141 | 136 | 6 | M39235 | |
| Coexpression | BENPORATH_SOX2_TARGETS | TCF20 MLLT10 HESX1 NFE2L3 PPP2R3A ARID1B PER2 KIF15 KLF5 MDC1 ZFYVE19 TMEM108 CAPRIN1 | 1.20e-04 | 734 | 136 | 13 | M3835 |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 1.46e-04 | 152 | 136 | 6 | M2938 | |
| Coexpression | DESCARTES_FETAL_EYE_MICROGLIA | 1.46e-04 | 152 | 136 | 6 | M40187 | |
| Coexpression | BENPORATH_ES_CORE_NINE_CORRELATED | 1.77e-04 | 100 | 136 | 5 | M14079 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.18e-08 | 179 | 136 | 8 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.02e-07 | 166 | 136 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-07 | 170 | 136 | 7 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-06 | 174 | 136 | 7 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.72e-06 | 186 | 136 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.72e-06 | 186 | 136 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.84e-06 | 188 | 136 | 7 | aa516273cdde53c8c0295f06830972388f890c97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 189 | 136 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 189 | 136 | 7 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.12e-06 | 192 | 136 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.51e-06 | 197 | 136 | 7 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.60e-06 | 198 | 136 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.44e-05 | 171 | 136 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-05 | 172 | 136 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 177 | 136 | 6 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 179 | 136 | 6 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 179 | 136 | 6 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 1.87e-05 | 179 | 136 | 6 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 180 | 136 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 1.99e-05 | 181 | 136 | 6 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 136 | 6 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-05 | 182 | 136 | 6 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 182 | 136 | 6 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 186 | 136 | 6 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 186 | 136 | 6 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 186 | 136 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-05 | 187 | 136 | 6 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-05 | 187 | 136 | 6 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 188 | 136 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-05 | 188 | 136 | 6 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 188 | 136 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 188 | 136 | 6 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-05 | 189 | 136 | 6 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-05 | 189 | 136 | 6 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | 368C-Myeloid-Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-05 | 189 | 136 | 6 | e62355be0d136e2b7c739848022292e9c6af7392 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-05 | 189 | 136 | 6 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.69e-05 | 191 | 136 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-05 | 192 | 136 | 6 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 2.77e-05 | 192 | 136 | 6 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 192 | 136 | 6 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 192 | 136 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-05 | 193 | 136 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-MAIT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 193 | 136 | 6 | 9aeb34d7a24f84abff38d7b8cf0ec707c08eb27f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 193 | 136 | 6 | 5da60321bcf761913eb30779b6d8b1e933c5e51e | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 194 | 136 | 6 | 20f81f457ab0a404600effe8beb91fe73d1cfc10 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-05 | 195 | 136 | 6 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-05 | 195 | 136 | 6 | 028622b234551b185977fbee10c06851a45456a5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 195 | 136 | 6 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-05 | 196 | 136 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-05 | 196 | 136 | 6 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | T_cells-CCR7+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.20e-05 | 197 | 136 | 6 | 904430779c42b51d3eec62cf0cdd501b17058d8b | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 3.39e-05 | 199 | 136 | 6 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-05 | 199 | 136 | 6 | 4e552015989defc32fe9068e0ba28521b2a1a09c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-05 | 199 | 136 | 6 | 42d57522aa05892f37790d0039d936e065565359 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-05 | 199 | 136 | 6 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-05 | 199 | 136 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-05 | 199 | 136 | 6 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-05 | 199 | 136 | 6 | 0554f41ae53c275c92fe692bd999d7578d244fce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.48e-05 | 200 | 136 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-05 | 200 | 136 | 6 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.05e-05 | 140 | 136 | 5 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.87e-05 | 147 | 136 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.16e-05 | 148 | 136 | 5 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.76e-05 | 150 | 136 | 5 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.07e-04 | 153 | 136 | 5 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 154 | 136 | 5 | a90c4c45685eae8d21d03479cfd5a23f6ed3ca07 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 155 | 136 | 5 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-04 | 157 | 136 | 5 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 160 | 136 | 5 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.32e-04 | 160 | 136 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 160 | 136 | 5 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 160 | 136 | 5 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | mild-Myeloid-CD14_Monocytes_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.32e-04 | 160 | 136 | 5 | a83568cd8a0b05642bacd43a8ec443e5ce314c4d | |
| ToppCell | Influenza_Severe-gd_T|World / Disease group and Cell class | 1.36e-04 | 161 | 136 | 5 | b3cdaed4d58d57e3c5dbc904a09388f3bf949407 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 1.44e-04 | 163 | 136 | 5 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-04 | 163 | 136 | 5 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 164 | 136 | 5 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-04 | 165 | 136 | 5 | e381bcd558745f3a60346f78b49d0b2672184baa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 165 | 136 | 5 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-04 | 165 | 136 | 5 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 166 | 136 | 5 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 166 | 136 | 5 | c0af93db981dfd448abc7efcd257f3e5ff066aae | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-04 | 166 | 136 | 5 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.61e-04 | 167 | 136 | 5 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 167 | 136 | 5 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-04 | 168 | 136 | 5 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-04 | 168 | 136 | 5 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-04 | 168 | 136 | 5 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 136 | 5 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 169 | 136 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 136 | 5 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 169 | 136 | 5 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.75e-04 | 170 | 136 | 5 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 172 | 136 | 5 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 173 | 136 | 5 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.06e-08 | 172 | 133 | 10 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.19e-07 | 170 | 133 | 9 | 1050_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A | 2.07e-06 | 193 | 133 | 9 | 413_DN | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; HL60; HG-U133A | 2.77e-06 | 200 | 133 | 9 | 1980_UP | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.99e-06 | 175 | 133 | 8 | 1058_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.40e-05 | 186 | 133 | 8 | 6874_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 1.90e-05 | 194 | 133 | 8 | 6173_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A | 2.04e-05 | 196 | 133 | 8 | 1558_DN | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 133 | 8 | 2941_DN | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 3304_UP | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 5576_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; HL60; HG-U133A | 2.12e-05 | 197 | 133 | 8 | 1577_DN | |
| Drug | pyrachlostrobin | TCF7 CD248 COBLL1 SYTL2 DAB2 PLXNB2 ITPR2 SSC5D CSF1 BAZ1A IPCEF1 TJP2 AFF1 NID1 PAPPA ADAMTSL4 | 2.13e-05 | 811 | 133 | 16 | ctd:C513428 |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; HL60; HG-U133A | 2.20e-05 | 198 | 133 | 8 | 1733_UP | |
| Drug | AC1L2FXT | 2.27e-05 | 10 | 133 | 3 | CID000071316 | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.28e-05 | 199 | 133 | 8 | 6968_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 1000uM; MCF7; HG-U133A | 2.28e-05 | 199 | 133 | 8 | 4_DN | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.28e-05 | 199 | 133 | 8 | 3346_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 2.36e-05 | 200 | 133 | 8 | 417_DN | |
| Drug | AC1L2XIZ | 4.13e-05 | 12 | 133 | 3 | CID000104803 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.22e-05 | 169 | 133 | 7 | 5231_DN | |
| Drug | 17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A | 7.48e-05 | 174 | 133 | 7 | 2673_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.75e-05 | 175 | 133 | 7 | 3787_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.03e-05 | 176 | 133 | 7 | 2639_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.62e-05 | 178 | 133 | 7 | 6276_DN | |
| Drug | cycloxydim | 8.64e-05 | 40 | 133 | 4 | CID000091765 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 9.25e-05 | 180 | 133 | 7 | 3688_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A | 9.91e-05 | 182 | 133 | 7 | 1231_DN | |
| Drug | 5-Methylcytosine | 1.01e-04 | 3 | 133 | 2 | ctd:D044503 | |
| Drug | prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.03e-04 | 183 | 133 | 7 | 6547_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.34e-04 | 191 | 133 | 7 | 4302_UP | |
| Drug | Hexestrol [84-16-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.34e-04 | 191 | 133 | 7 | 6077_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.38e-04 | 192 | 133 | 7 | 2523_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 3969_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 4246_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 3725_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 1217_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 4573_UP | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; HL60; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 2132_UP | |
| Drug | Atovaquone [95233-18-4]; Up 200; 11uM; HL60; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 2480_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 1207_DN | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; HL60; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 3034_UP | |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; MCF7; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 2823_DN | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; HL60; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 2409_DN | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 1688_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 6926_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 6938_DN | |
| Drug | Troleandomycin [2751-09-9]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 1465_DN | |
| Drug | DO 897/99; Up 200; 8.2uM; HL60; HG-U133A | 1.57e-04 | 196 | 133 | 7 | 1728_UP | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3679_DN | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3083_UP | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 5510_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 4844_DN | |
| Drug | LY 294002; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 1216_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3971_UP | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; HL60; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3064_UP | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 6782_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 4774_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 6941_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 2468_UP | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 5780_UP | |
| Drug | tamoxifen citrate; Down 200; 1uM; MCF7; HG-U133A | 1.62e-04 | 197 | 133 | 7 | 143_DN | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 2630_UP | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 1697_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 6974_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 5807_DN | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; HL60; HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1983_UP | |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; HL60; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1861_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; HL60; HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1593_UP | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 2090_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; HL60; HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1566_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1690_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 6241_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1464_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; PC3; HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1926_UP | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 4701_UP | |
| Drug | exemestane; Down 200; 0.01uM; MCF7; HG-U133A | 1.72e-04 | 199 | 133 | 7 | 165_DN | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; HL60; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 3050_UP | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; HL60; HG-U133A | 1.72e-04 | 199 | 133 | 7 | 1559_DN | |
| Drug | aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 6164_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 3730_UP | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 3465_DN | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 6992_DN | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 3008_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 7015_DN | |
| Disease | pulse pressure measurement | ZNF438 USP36 TET2 COBLL1 TRIOBP ZC3H11B PLXNB2 ARID5A PHC2 ARID1B KIAA1549L FAM13A KIF15 MTF1 ABI2 MYPN TET1 TRIM8 ZFHX3 HYDIN | 6.95e-06 | 1392 | 137 | 20 | EFO_0005763 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 8.87e-06 | 103 | 137 | 6 | EFO_0008595, EFO_0020944 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 2.14e-05 | 2 | 137 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | total blood protein measurement | ZNF438 TCF7 DAB2 ZC3H11B KMT2D CSF1 ATXN2 NFATC3 SIGLEC1 HYDIN | 4.95e-05 | 449 | 137 | 10 | EFO_0004536 |
| Disease | cortical surface area measurement | ZNF438 TET2 CELF5 SREBF1 TRIOBP PLXNB2 PHC2 ARID1B FAM13A ATXN2 MDC1 TRIM8 AFF1 PAPPA ZFHX3 MPHOSPH9 SH3RF3 PCDH7 | 5.28e-05 | 1345 | 137 | 18 | EFO_0010736 |
| Disease | red blood cell density measurement | TET2 COBLL1 RAB11A ZC3H11B RBBP8NL PHC2 ARID1B FAM13A CIITA ATXN2 BAZ1A BRD4 TJP2 AFF1 | 6.33e-05 | 880 | 137 | 14 | EFO_0007978 |
| Disease | HbA1c measurement | USP36 TET2 CLASP1 COBLL1 ZC3H11B TNRC6C ZKSCAN5 HAVCR1 ATXN2 ZNF341 MYPN TET1 | 7.68e-05 | 675 | 137 | 12 | EFO_0004541 |
| Disease | triglyceride measurement, alcohol drinking | 1.01e-04 | 99 | 137 | 5 | EFO_0004329, EFO_0004530 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.11e-04 | 101 | 137 | 5 | EFO_0004530, EFO_0007878 | |
| Disease | Anophthalmia-microphthalmia syndrome | 1.22e-04 | 21 | 137 | 3 | cv:C5680330 | |
| Disease | advanced glycosylation end product-specific receptor ligand measurement | 1.22e-04 | 21 | 137 | 3 | EFO_0010762 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.26e-04 | 55 | 137 | 4 | EFO_0022234 | |
| Disease | vesicoureteral reflux (is_marker_for) | 2.12e-04 | 5 | 137 | 2 | DOID:9620 (is_marker_for) | |
| Disease | breast cancer (is_marker_for) | 2.33e-04 | 185 | 137 | 6 | DOID:1612 (is_marker_for) | |
| Disease | Intellectual Disability | 2.52e-04 | 447 | 137 | 9 | C3714756 | |
| Disease | breast carcinoma (is_marker_for) | 2.56e-04 | 66 | 137 | 4 | DOID:3459 (is_marker_for) | |
| Disease | disease of metabolism (is_implicated_in) | 3.17e-04 | 6 | 137 | 2 | DOID:0014667 (is_implicated_in) | |
| Disease | kidney disease (is_marker_for) | 5.88e-04 | 8 | 137 | 2 | DOID:557 (is_marker_for) | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 5.99e-04 | 307 | 137 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | mean corpuscular hemoglobin concentration | SETD1B CLASP1 COBLL1 RAB11A GPR152 GON4L TSC2 E2F8 ITPR2 ATXN2 BAZ1A BRD4 AFF1 N4BP2L2 | 6.46e-04 | 1105 | 137 | 14 | EFO_0004528 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 6.52e-04 | 148 | 137 | 5 | C0279702 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 6.59e-04 | 225 | 137 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | valine measurement | 8.53e-04 | 40 | 137 | 3 | EFO_0009792 | |
| Disease | Kidney Neoplasm | 8.53e-04 | 40 | 137 | 3 | C0022665 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 9.17e-04 | 41 | 137 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 9.17e-04 | 41 | 137 | 3 | C0858252 | |
| Disease | Congenital small ears | 9.17e-04 | 41 | 137 | 3 | C0152423 | |
| Disease | cup-to-disc ratio measurement | 9.29e-04 | 430 | 137 | 8 | EFO_0006939 | |
| Disease | Parkinson disease, late-onset | 9.40e-04 | 10 | 137 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 9.40e-04 | 10 | 137 | 2 | 168600 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement | 1.05e-03 | 43 | 137 | 3 | EFO_0007788, EFO_0008343 | |
| Disease | triglycerides in large LDL measurement | 1.05e-03 | 43 | 137 | 3 | EFO_0022319 | |
| Disease | waist-hip ratio, sexual dimorphism | 1.15e-03 | 11 | 137 | 2 | EFO_0004343, EFO_0005951 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.19e-03 | 99 | 137 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | Malignant neoplasm of kidney | 1.20e-03 | 45 | 137 | 3 | C0740457 | |
| Disease | Pancreatic Neoplasm | 1.24e-03 | 100 | 137 | 4 | C0030297 | |
| Disease | monocyte count | TET2 ATF7 CRYBG2 CLASP1 CECR2 RAB11A GON4L MLLT10 CSF1 CIITA ATXN2 BAZ1A KLF5 DUSP16 ABHD16A | 1.25e-03 | 1320 | 137 | 15 | EFO_0005091 |
| Disease | ovarian serous carcinoma | 1.28e-03 | 46 | 137 | 3 | EFO_1001516 | |
| Disease | Leukemia, Myelocytic, Acute | 1.31e-03 | 173 | 137 | 5 | C0023467 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TET2 TCF20 ZKSCAN5 PHC2 ARID1B FAM13A ATXN2 NINL ZFHX3 PCDH7 MAML3 | 1.32e-03 | 801 | 137 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Malignant neoplasm of pancreas | 1.33e-03 | 102 | 137 | 4 | C0346647 | |
| Disease | Clear Cell Meningioma | 1.37e-03 | 12 | 137 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 1.37e-03 | 12 | 137 | 2 | C1334271 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.37e-03 | 12 | 137 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Benign Meningioma | 1.37e-03 | 12 | 137 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 1.37e-03 | 12 | 137 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 1.37e-03 | 12 | 137 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 1.37e-03 | 12 | 137 | 2 | C1527197 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.37e-03 | 12 | 137 | 2 | C3160718 | |
| Disease | Meningiomas, Multiple | 1.37e-03 | 12 | 137 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 1.37e-03 | 12 | 137 | 2 | C0457190 | |
| Disease | Angiomatous Meningioma | 1.37e-03 | 12 | 137 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 1.37e-03 | 12 | 137 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 1.37e-03 | 12 | 137 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 1.37e-03 | 12 | 137 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 1.37e-03 | 12 | 137 | 2 | C0334609 | |
| Disease | Transitional Meningioma | 1.37e-03 | 12 | 137 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 1.37e-03 | 12 | 137 | 2 | C0334610 | |
| Disease | Spinal Meningioma | 1.37e-03 | 12 | 137 | 2 | C0347515 | |
| Disease | Intracranial Meningioma | 1.37e-03 | 12 | 137 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 1.37e-03 | 12 | 137 | 2 | C3163622 | |
| Disease | Malignant Meningioma | 1.37e-03 | 12 | 137 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 1.37e-03 | 12 | 137 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 1.37e-03 | 12 | 137 | 2 | C1565950 | |
| Disease | age of onset of multiple sclerosis | 1.37e-03 | 12 | 137 | 2 | OBA_2001029 | |
| Disease | Parasagittal Meningioma | 1.37e-03 | 12 | 137 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 1.37e-03 | 12 | 137 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 1.37e-03 | 12 | 137 | 2 | C1384408 | |
| Disease | Secretory meningioma | 1.37e-03 | 12 | 137 | 2 | C1384406 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.53e-03 | 106 | 137 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | bipolar disorder | 1.54e-03 | 577 | 137 | 9 | MONDO_0004985 | |
| Disease | advanced glycosylation end product-specific receptor, soluble measurement | 1.61e-03 | 13 | 137 | 2 | EFO_0020131 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.70e-03 | 109 | 137 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.73e-03 | 51 | 137 | 3 | EFO_0022240 | |
| Disease | waist-hip ratio | TET2 COBLL1 SYTL2 DAB2 ZC3H11B MLLT10 SSC5D PPP2R3A FAM13A CIITA ATXN2 TRIM8 NID1 MAML3 | 1.73e-03 | 1226 | 137 | 14 | EFO_0004343 |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.76e-03 | 110 | 137 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | sexual dimorphism measurement | USP36 TET2 KMT2B CD248 COBLL1 ZC3H11B PTPN23 TSC2 SSC5D ZNF341 PAPPA ZFHX3 B4GALNT3 | 1.97e-03 | 1106 | 137 | 13 | EFO_0021796 |
| Disease | open-angle glaucoma | 2.02e-03 | 191 | 137 | 5 | EFO_0004190 | |
| Disease | total lipids in medium VLDL | 2.04e-03 | 54 | 137 | 3 | EFO_0022153 | |
| Disease | body fat percentage | 2.06e-03 | 488 | 137 | 8 | EFO_0007800 | |
| Disease | cortical thickness | ZNF438 CELF5 KMT2B SREBF1 TRIOBP MLLT10 ARID1B ATXN2 BAZ1A AFF1 TMEM108 SH3RF3 PCDH7 | 2.08e-03 | 1113 | 137 | 13 | EFO_0004840 |
| Disease | triglycerides in medium VLDL measurement | 2.15e-03 | 55 | 137 | 3 | EFO_0022155 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.16e-03 | 15 | 137 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | triglycerides in large VLDL measurement | 2.27e-03 | 56 | 137 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 2.27e-03 | 56 | 137 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 2.27e-03 | 56 | 137 | 3 | EFO_0022325 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 2.27e-03 | 56 | 137 | 3 | EFO_0022316 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.27e-03 | 56 | 137 | 3 | EFO_0022251 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.39e-03 | 57 | 137 | 3 | EFO_0022284 | |
| Disease | T-Cell Lymphoma | 2.46e-03 | 16 | 137 | 2 | C0079772 | |
| Disease | metabolic syndrome | 2.47e-03 | 200 | 137 | 5 | EFO_0000195 | |
| Disease | testosterone measurement | ZNF438 TET2 SPEM3 CECR2 COBLL1 ZC3H11B ZKSCAN5 OPHN1 ARID1B MYPN DUSP16 MCM9 AFF1 ZFHX3 | 2.48e-03 | 1275 | 137 | 14 | EFO_0004908 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.48e-03 | 121 | 137 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | triglycerides in IDL measurement | 2.51e-03 | 58 | 137 | 3 | EFO_0022149 | |
| Disease | triglycerides in VLDL measurement | 2.63e-03 | 59 | 137 | 3 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 2.63e-03 | 59 | 137 | 3 | EFO_0022301 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 2.63e-03 | 59 | 137 | 3 | EFO_0022248 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 2.63e-03 | 59 | 137 | 3 | EFO_0022260 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 2.76e-03 | 60 | 137 | 3 | EFO_0021898 | |
| Disease | total lipids in VLDL measurement | 2.76e-03 | 60 | 137 | 3 | EFO_0022314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALHQNSPSPVPSRTP | 826 | Q09472 | |
| PQASPAVHLPESPQS | 286 | Q03989 | |
| PTELSVHTPSPQAEP | 216 | Q6UY14 | |
| VHTPSPQAEPLSPET | 221 | Q6UY14 | |
| STPPHLNQHAVVSPP | 846 | O60885 | |
| QKPSPEPSQDSPHSD | 516 | Q6L9W6 | |
| PQASQVPPPSGFTVH | 261 | P33076 | |
| PTNQTSPISPTHPHS | 626 | Q9HCU0 | |
| PASVPETPTAVTAPH | 26 | O95870 | |
| SAPPLSHTPNADFQP | 41 | P05549 | |
| VAVPTHSQPSPTPSN | 476 | Q92560 | |
| PQPPGSQSESSSHPA | 836 | Q8NFD5 | |
| HPTLPSPTSVITQAP | 166 | P17544 | |
| PPGAENSTSHQPATP | 521 | Q9HBB8 | |
| TPSVIQHVGQPPATP | 591 | Q6W2J9 | |
| PQAASPSVPEPHSLT | 331 | Q14444 | |
| PSVPEPHSLTPVAQA | 336 | Q14444 | |
| TQLPHPTPPLQTDCT | 996 | Q9BXF3 | |
| SPPSKIPPHQSDENS | 366 | Q53SF7 | |
| PVVSSTPPTGHPVQF | 336 | Q9NYB9 | |
| HVTPSNVDQVSTPPA | 1536 | Q9NRL2 | |
| VLPSQTPQPAHHTPD | 231 | Q96K21 | |
| RPSLPTQAHTTQPTP | 1016 | P49792 | |
| PSNNVVPIHVPPTTE | 191 | P62491 | |
| LPAPSHPASTNEPIV | 651 | O94776 | |
| HQTPNGTITSSIEPP | 616 | O60890 | |
| SIQAPIPSHTAPRPN | 886 | Q9H3S7 | |
| VPPSIHPSKQGSPTE | 946 | Q14571 | |
| PPNQPVPASSHSIVS | 146 | Q02548 | |
| QSSPHDSIAIIPPPQ | 421 | P98082 | |
| SNIFPAPAVSTQPPS | 596 | P98082 | |
| EPHPSTSTAQPVTPK | 1126 | Q14676 | |
| APEPHPTTSTDQPVT | 1616 | Q14676 | |
| IPQSPPEGENTHSPL | 516 | O60732 | |
| LQSSHESPQSPPEGP | 791 | O60732 | |
| VPTQPHAPIPTFGQT | 2611 | Q16787 | |
| AEDPQSPKTPPHFQT | 1136 | Q9NS87 | |
| TPNSTPAAPSSNHPA | 36 | Q96JK9 | |
| PQETPHATSHPAVPI | 106 | P16150 | |
| QHPTATPTEIPTPQS | 816 | Q9P107 | |
| SHNPPSEAATPPVAR | 651 | Q99700 | |
| PPTVATHAPQTLNPS | 276 | Q6ZQN5 | |
| PPLVSNTAPETVPSH | 161 | Q12766 | |
| PSQPQFPSHPTLTSE | 926 | O15055 | |
| SPSSIPVTPPGQDHV | 576 | O15031 | |
| PLPTVQLHPQSPTAG | 1001 | O60245 | |
| PSSPDHESPSQESPN | 161 | Q9C000 | |
| STVAPPIHQGPAVPT | 921 | P14543 | |
| HLQPTAPESTSEPFP | 501 | Q9Y4A8 | |
| QPVVTPSVQPSLHPA | 401 | Q5T1M5 | |
| HVPNPPSGISFPSVV | 61 | Q9UBX0 | |
| SNPNHPPEVLTLDPT | 281 | Q99550 | |
| SVVPHPSPTPLSQEE | 101 | Q8NC54 | |
| NVQTPAPAASSVPSP | 411 | Q8TDT2 | |
| TTSPSHPPQTVPGSN | 361 | Q96MU8 | |
| PNNSHTAPPVTEVTV | 111 | Q9UQV4 | |
| NQTIVHSPAPSSEPP | 1801 | Q9UMN6 | |
| LQPTENHASPSPVPE | 211 | Q6ZVL6 | |
| SPNSAVNPHTVPPAC | 761 | Q13219 | |
| DDTEVPPSPPNSHSF | 631 | O94988 | |
| SSPRPLSPVPHVNNV | 686 | Q06190 | |
| SAQQSVVVSPPPPHS | 391 | Q8NDX5 | |
| PHVQAPSLEPSVSPQ | 431 | Q09013 | |
| TPPPAAASAQSLHPV | 151 | P49335 | |
| TPVPTASPVKAINHP | 281 | Q86XN7 | |
| SSAVHTPQPSIPNPT | 321 | Q86XN7 | |
| SPAAAHTASPEPPTQ | 466 | Q8NC74 | |
| HQSETPQISSSPLPP | 2171 | Q4G0P3 | |
| EIAAETPPPPHASQT | 161 | Q8WWN9 | |
| TPPPPHASQTQSLTA | 166 | Q8WWN9 | |
| PALASSHPVPIQNPS | 716 | A0AVK6 | |
| AIPSSDPASVSPHQP | 196 | P09603 | |
| TQHSPVPPEEVTGPS | 136 | Q9Y603 | |
| VLGVPHNPAPPTSTV | 31 | C9JQL5 | |
| HPEPQPTNTPLSATV | 6 | Q6ZV77 | |
| LPQEQEPTSEPPVSH | 186 | Q2WGN9 | |
| GQRPVHPASVPSVPS | 351 | Q9BY84 | |
| HPASVPSVPSVQPSL | 356 | Q9BY84 | |
| PTAAITPIAHSVPQP | 371 | Q8N6W0 | |
| EHVTVPGQPPAPSTT | 411 | Q8N1P7 | |
| HSPETPQFPPTTGAV | 1976 | Q3T8J9 | |
| EPVPHLQTPTSEPQT | 516 | Q8TBE0 | |
| SHQIPPPIQTAAEST | 546 | Q2TAC2 | |
| STRTPPTANHPVEPV | 326 | O95487 | |
| SPQNTLAAPTGHPPT | 976 | Q5VT52 | |
| QSPAPSENPDVSHPE | 471 | Q9BZV2 | |
| VAPHLAQPTGSQSPP | 541 | Q969Z0 | |
| PFEQTIPSLNPGSHP | 51 | O43364 | |
| VPAQCTVPSHPQSTP | 866 | Q9NXL9 | |
| TVPSHPQSTPVHSPD | 871 | Q9NXL9 | |
| SPPTPTTPGFQVQHS | 126 | P43354 | |
| APLPAETAHTQPSPN | 61 | A7E2F4 | |
| TVPTQPDNPFSHPDK | 541 | Q9HCH5 | |
| QNSESPASPPVAVPH | 1351 | Q9HCJ0 | |
| SQPPDRQSEPATHPA | 466 | Q96KN7 | |
| QVHQAEPKTPSSPPS | 421 | Q8IYG6 | |
| QPPEVPVPHSTQFAA | 466 | Q14872 | |
| QSQAPPTLPATPHSS | 346 | Q9H6K5 | |
| PPIQVPHSLTSPSLQ | 586 | Q9H6K5 | |
| PLPRQNHEPVATSPS | 216 | Q96D42 | |
| NHEPVATSPSSPQPA | 221 | Q96D42 | |
| PTTTPPETQQSPHLS | 426 | Q5FBB7 | |
| QPQDSATFAHTPPPA | 371 | Q9UPS6 | |
| PQTPVFPSTHDPRTV | 1556 | Q9UPS6 | |
| NPEPPATTQGPHTLD | 3131 | Q9P2P6 | |
| PDPITTLNPTVTPHF | 1161 | A1L4H1 | |
| EATQSPAPAPAPASH | 886 | Q9Y2I6 | |
| VAHTATQQPAAPAPP | 421 | Q68BL8 | |
| SPSQPPADQSPHTLR | 631 | Q17R89 | |
| PVPAVAHSPPATVEA | 251 | A6NEL2 | |
| TKPATPQPHPSTTAI | 376 | Q7RTU9 | |
| SPSRPAQHDPPQSSF | 951 | Q9H2D6 | |
| ASPPGVPPVSLHTQV | 191 | P36956 | |
| PSTGVTEPLTPHQPN | 1926 | Q8NFU7 | |
| PFPTITANPSPSHQI | 781 | P55197 | |
| PSAPQSLPEPVASAH | 451 | P51825 | |
| PFSQPNSIPTAPSHK | 1141 | Q7Z460 | |
| AETPPPPHASQTQSL | 626 | G9CGD6 | |
| NVGSPPKSPTHASPQ | 411 | A0JNW5 | |
| VPTSPNIQPSPAHET | 506 | Q8IXK0 | |
| SHIPPPVPSEFNDVS | 1001 | Q5W0Q7 | |
| PSAAPTAVQQAPTPA | 96 | Q9BYN7 | |
| TPQHTSSRPPEPQKA | 1131 | Q9UDY2 | |
| QPLPAPEAAHTTGPT | 226 | P19532 | |
| PTPAQTPAHIQAHTP | 271 | A0A1B0GUW6 | |
| VPFHPSSSVPPAINS | 201 | Q5PRF9 | |
| PLQTSQPTPPEELHT | 46 | A6NJ88 | |
| SRSPPSVSPTHDPQV | 736 | Q8TEJ3 | |
| VESSENVPSPTHPPV | 141 | O75152 | |
| VPVSQPDPLPASDHS | 261 | Q6ZN55 | |
| PFPDAPEATTHTQLP | 801 | Q7Z410 | |
| IPSPIVHQPFQVTPT | 781 | Q12968 | |
| VHQPFQVTPTPPVGS | 786 | Q12968 | |
| SGPVSVVVNHPPLTP | 401 | Q9BZZ2 | |
| PISNPSPAASVVQSP | 366 | Q9UGU0 | |
| FNSPHPTPAPADISQ | 166 | P36402 | |
| VESSENVPSPKHPPV | 141 | A0A1B0GTU1 | |
| HQQPSPTSVLPTEVA | 666 | A8K0R7 | |
| SSPVQHQSIPPGTRP | 71 | Q9UC06 | |
| AQHLSATVAEPPVPP | 161 | Q8TF50 | |
| TKPATPQPHPSTTAI | 376 | A6NGW2 | |
| PTISKTVNPTPDPHQ | 11 | Q9BXG8 | |
| GAQPVHSSPVFPPSQ | 431 | Q9BZR9 | |
| PHSASPVSPDGVQIP | 321 | Q6PJF5 | |
| EAPPSQSPNPSTHVC | 456 | Q6N021 | |
| PVTNTHGSLNPPATP | 206 | Q7Z4V0 | |
| HQLPEASEPPQSPSE | 796 | Q9P275 | |
| SPHPLTVDTQPEQAP | 161 | Q9Y2L8 | |
| PSHSKAPAQTPAEPT | 1771 | P49815 | |
| TSQSAAHSNDSPPPP | 3586 | Q15911 | |
| PQGASTTPQAPTHPS | 376 | Q6UXF1 | |
| HQSETTAPPPAPTQA | 171 | Q13887 | |
| PSSQLPTEAQLPPTH | 4326 | O14686 | |
| EPLTAPPTNGLPHTQ | 986 | Q9P206 | |
| NSVEPSHKSTQRPPP | 546 | Q92802 | |
| TNLAAIEPQPSPPHS | 551 | Q86TC9 |